X37 is Drug Development At The Speed of AI Drugging the Undruggable Our AI-driven approach to drug development lets us work on the most difficult-to-target.....
We leverage the latest advances in drug discovery technology by building partnerships with AI companies that specialize in cutting-edge technology designed to identify small molecules that can potently and selectively bind difficult-to-drug targets. Our flexible approach allows us to select the best technology for every target in our pipeline...
Our AI-driven approach to drug development lets us work on the most difficult-to-target proteins across the broadest possible chemical space. We focus on targets of high therapeutic value that have challenged the conventional drug discovery industry - sparking new hope for safe, effective therapies in these diseases. Our current targets have established causal roles in autoimmune disease, cancer, and anticoagulation.